AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
SIKA.SW
ACCE-researched

Sika AG (SIKA.SW) fair value

Basic Materials · Specialty Chemicals · SIX · Switzerland
CHF 180.20-2.33%
Market cap CHF 28.9BNext earnings 2027-02-18Updated Oct 22, 2026
Add earnings to calendarGoogle
Our verdict
Trades 68% above our fair value
Price
CHF 180.20
Model fair valueConfidence: good
CHF 107
Model range
CHF 77.70 to CHF 129
Fair value CHF 107
Price CHF 180
4 models fit Sika AG and they disagree: 0 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Bronze51
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionSika AG (SIKA.SW)
Fair value (4 models)
CHF 107
ACCE price target
CHF 197
Rating
Overvalued
Horizon
12 months
Fair value published on 22 Oct 2026, 12:04 CEST.
ACCE price target published on 22 Oct 2026, 16:00 CEST.
Rating published on 22 Oct 2026, 12:04 CEST.
Price used: CHF 180 at the close on 23 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
68.0% above
-40.5% to fair value
ACCE score
52
out of 100
P/E
27.8x
forward 21.6x
1-year return
+1.8%
Dividend yield
2.01%

Sika AG in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Sika makes construction chemicals: concrete admixtures, waterproofing membranes, structural adhesives and sealants, and flooring systems sold alongside the building work they go into, which gives it a 55.2% gross margin that few industrial peers match. Its edge is specification: once an engineer writes a Sika product into a project, the contractor tends to stay with it, and that stickiness is what supports the premium multiple. Revenue fell 1.5%, so the near-term story depends on volumes recovering in construction and on pricing holding through the soft patch. At 22.0x forward earnings against a 28.5x trailing multiple, the market is pricing in a clear earnings rebound, and a 16.0% ROE with a 14.3% operating margin shows the business still converts capital well while it waits. Worth a deeper look if you believe construction activity turns in the next 12 to 18 months; the flat top line is the thing to test.

AI-assisted·How I use AIWritten Oct 23, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Revenue and earnings declining
    Revenue fell 1.5% and earnings fell 0.6% year over year, breaking the 5-year revenue CAGR of +7.3%. Worth watching whether this is cyclical or structural.
  • moderate
    Rich valuation multiples
    P/E of 28.7 and EV/EBITDA of 17.2 leave little room for further earnings softness, with the stock at CHF 180.20.

AI research notes

AI-assisted·How I use AIWritten Oct 22, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Sika generated CHF 1.2B of free cash flow over the last twelve months, a sizeable cash engine for a chemicals business.
  • Return on equity of 16.0% shows the company earns solid profit on the capital shareholders have put in.
  • Analysts' mean price target of CHF 203.06 sits 10.1% above the current share price, implying further upside in their view.
Why it could disappoint
  • Revenue fell 1.5% year over year, breaking a 5-year average growth rate of 7.3% per year.
  • Earnings per share missed expectations by 24.5% in the latest quarter, a sharp disappointment for investors.
  • At 28.7 times trailing earnings the shares look expensive, and return on invested capital of 7.0% is modest for that price.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Feb 18, 2027
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where SIKA.SW's valuation models land
Price
CHF 180.20
Model fair value
CHF 107
Model range
CHF 77.70 to CHF 129
Fair value CHF 107
Price CHF 180
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-1.3%
1 month
-2.6%
3 months
+15.6%
6 months
+24.6%
YTD
+10.8%
1 year
+1.8%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
22 Oct 2026, 16:00 CESTACCE price targetCHF 197first publicationCHF 185
22 Oct 2026, 12:04 CESTRatingOvervaluedfirst publicationCHF 185
22 Oct 2026, 12:04 CESTFair valueCHF 107first publicationCHF 185

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in CHF. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full SIKA.SW page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value53Quality63Momentum83Total52
Valuation
Trailing P/E
27.8x
Forward P/E
21.6x
PEG
no data
P/B
4.36x
EV / Revenue
3.2x
Book value/sh
CHF 42.47
Enterprise value
CHF 35.1B
Profitability
ROE
16.0%
FCF yield
4.21%
ROIC
7.0%
Health and risk
Debt / equity
0.83
Dividend yield
2.01%
Beta
1.18

Price

+2.4% · 1Y

Ask anything about SIKA.SW

Answered from Sika AG fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 80% of peers
low 15.8x27.8xhigh 90.2x
ROEbetter than 33% of peers
low -6%16%high 23%
Div yieldbetter than 67% of peers
low 1.2%2.0%high 2.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
SIKA.SW Sika AGCHF 180.20CHF 10768% above27.8x16.0%6352
DSFIR.AS DSM-Firmenich AG€108.80€36203% above-1.9%4352
GIVN.SW GivaudanCHF 3975.00CHF 1683136% above38.8x22.3%7552
PPG PPG Industries Inc. Common Stock$113.09$8534% above15.8x19.3%6859
EMSN.SW EMS-CHEMIE HOLDING AGCHF 883.50CHF 304191% above43.2x22.7%9159
IFF International Flavors & Fragrances Inc. Common Stock$93.83$5279% above90.2x-5.5%4948
ASIANPAINT.NS Asian Paints₹2284.80--46.4x20.9%8459

Sector report card

Where SIKA.SW ranks against its sector peers on each metric.

Computing percentiles…